Boston Scientific To Pay J&J $1.7B In Stent Settlement

By Ryan Davis

Law360, New York (February 01, 2010, 6:33 PM ET) -- Boston Scientific Corp. has agreed to pay Johnson & Johnson Inc. $1.725 billion to resolve a handful of stent patent disputes between the companies, including two that had been set to go to trial Monday.

Boston Scientific and J&J unit Cordis Corp. said in separate statements Monday that the settlement will avert two jury trials in the U.S. District Court for the District of Delaware on the issue of damages.

The deal is the second major settlement between the companies in four months. Boston Scientific agreed...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles